IL6 and obesity disorder: By incorporating adiposity, TyG-BMI captures obesity’s contribution to IR—through pro-inflammatory adipokines (e.g., TNF-α, IL-6) and reduced adiponectin—amplifying systemic inflammation and metabolic dysfunction (30).